Zumla, A;
Abubakar, I;
(2017)
Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials.
The Lancet Respiratory Medicine
, 5
(4)
pp. 247-248.
10.1016/S2213-2600(17)30091-7.
Preview |
Text
Zumla_Accepted Lancet Resp Med Comment Zumla-Abubakar 2.pdf - Accepted Version Download (394kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2213-2600(17)30091-7 |
| Publisher version: | http://dx.doi.org/10.1016/S2213-2600(17)30091-7 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Critical Care Medicine, Respiratory System, General & Internal Medicine, HOST-DIRECTED THERAPIES, RESISTANT TUBERCULOSIS, BIOMARKERS, REGIMENS |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10048897 |
Downloads since deposit
Loading...Download activity - last month
Loading...Download activity - last 12 months
Loading...Downloads by country - last 12 months
| 1. |  United States | 7 |
| 2. |  China | 5 |
| 3. |  India | 2 |
| 4. |  Indonesia | 1 |
| 5. |  Zambia | 1 |
| 6. |  Iran, Islamic Republic of | 1 |
| 7. |  Germany | 1 |
Archive Staff Only
 |
View Item |
